RTTNews | Jul 28, 2021 07:37AM EDT

07:37 Wednesday, July 28, 2021 (RTTNews) - I-Mab Announces IND Acceptance For Phase 2 Trial Of Efineptakin Alfa In Combination With PD-1 Therapy In China

For comments and feedback: contact editorial@rttnews.comCopyright(c) 2021 RTTNews.com. All Rights Reserved